| Catalog No. |
Size |
Price |
Figures |
|---|
Z00023-1 mg
| 1 mg | $ 420.00 |
References:
- Kusov Y, et al. Silencing of hepatitis A virus infection by small interfering RNAs. J. Virol. Jun 2006; 80(11): 5599-5610.
- Nainan OV, et al. Diagnosis of hepatitis a virus infection: a molecular approach. Clin. Microbiol. Rev. Jan 2006; 19(1): 63-79.
- Dotzauer A, et al. IgA-coated particles of Hepatitis A virus are translocalized antivectorially from the apical to the basolateral site of polarized epithelial cells via the polymeric immunoglobulin receptor. J. Gen. Virol. Oct 2005; 86(Pt 10): 2747-2751.
|
|---|
| Full Name | | Hepatitis A Virus (HAV) P2C-P3A |
|
| Abbreviated Name-1 | Hepatitis P2C-P3A |
|---|
| Description | Hepatitis A Virus (HAV) P2C-P3A is an E. coli-derived recombinant. The protein Hepatitis A Virus (HAV) P2C-P3A contains the P2C-P3A immunodominant region. The protein contains the HAV core proteins P2C-P3A immunodominant regions, amino acids: (1,492-1,606). HAV core proteins are purified by proprietary chromatographic techniques. |
|---|
| Source | E. coli |
|---|
| Purity | Protein is >90% pure as determined by 10% PAGE (coomassie staining). |
|---|
| Storage | Protein is shipped at ambient temperature. Upon arrival, store at -20°C. |
|---|
| Concentration | 1 mg/ml in 10 mM CBB, pH9.6, 0.1% SDS, glycerol 50%. |
|---|
| Stability | Five years frozen. One month in solution at room temperature. |
|---|
| Specificity | Immunoreactive with sera of HAV-infected individuals. |
|---|
| Applications | Antigen in ELISA and Western blots, excellent antigen for detection of HAV with minimal specificity problems. |
|---|
